Back to search
FDAFDA · Food and drugs·Recall number Z-1742-2020

The VITEK 2 Gram-positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in-vitro test to determine susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed.

Published April 29, 2020 · Recall initiated: March 11, 2020

Summary

FDA records medical device Class II recall Z-1742-2020, published April 29, 2020 and initiated March 11, 2020. Recalling firm: Biomerieux Inc; Status: Ongoing; Reported quantity: 1698 cartons (15,940 cards); Lot: VITEK 2AST-P652 Test Kit with Catalog #421857 and Lot# 8021232403 Manufactured 11OCT2019, Expires 11APR2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential for the occurrence of false positive OXSF results for some Staphylococcus aureus strains in conjunction with the VITEK 2 AST-P652 test card (ref. 421857, lot 8021232403). .

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Biomerieux Inc
Distributor
No distribution within the United States. Foreign distribution locations: Netherlands, Luxembourg, Belgium
Lot
VITEK 2AST-P652 Test Kit with Catalog #421857 and Lot# 8021232403 Manufactured 11OCT2019, Expires 11APR2021
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was The VITEK 2 Gram-positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in-vitro test to determine susceptibility of Staphylococcus spp., Enterococcus spp., and S. agalactiae to antimicrobial agents when used as instructed. recalled?

Yes. FDA published recall Z-1742-2020 on April 29, 2020. Reported hazard: There is a potential for the occurrence of false positive OXSF results for some Staphylococcus aureus strains in conjunction with the VITEK 2 AST-P652 test card (ref. 421857, lot 8021232403). .

What should I do if I have this product?

Voluntary: Firm initiated · Letter